CA1078731A
Expired / Lapsed
CA
⏱️ 0.0 years remaining
Skeletal imaging kit utilizing triethylene tetramine hexa (methylene phosphonic acid)
Assignee: Merck Frosst Canada and Co
•
Filing: 1976-12-16
•
Granted: 1980-06-03
•
Expires: 1996-12-16
Abstract
Abstract Abstract of the Disclosure This invention relates to a novel diagnostic kit for use in radiographic bone scanning. More particularly, it relates to a kit comprising ingredients employed in the preparation of an intravenous injection of a complex of Technetium-99m, stannous ion, and an organic phosphonate identified as triethylene tetramine hexa (methylene phos-phonic acid).
Inventors
- 👤 Richard E. Rolleston
- 👤 Jacques A. Nadeau
Bibliographic Details
Application Number
—
Jurisdiction
CA
Data Source
google_patents
Last Synchronized
2026-10-26 02:36
CPC Classifications
A; A61; A61K; A61K51/00; A61K51/12; A61K51/1241; A61K2123/00
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
39 words
A kit for the preparation of an injectable solution incorporating Technetium 99m which comprises in a single sterile container a freeze-dried mixture of triethylene tetramine hexa (methylene phosphonic acid) or a water-soluble salt thereof and a water-soluble tin salt.
Claim 2
Dependent Claim
39 words
A kit for the preparation of an injectable solution incorporating Technetium 99m which comprises in a single sterile container a freeze-dried mixture of triethylene tetramine hexa (methylene phosphonic acid) or a water-soluble salt thereof and a water-soluble tin salt.
Claim 3
Dependent Claim
64 words
A kit for the preparation of an injectable solution incorporating Technetium 99m which comprises in a single sterile container a freeze-dried mixture of triethylene tetramine hexa (methylene phosphonic acid) or a water-soluble salt thereof and a water-soluble tin salt in a ratio by weight of from 10-100 parts of triethylene tetramine hexa (methylene phosphonic acid) and 1 part of tin as stannous chloride? dihydrate.
Claim 4
Dependent Claim
64 words
A kit for the preparation of an injectable solution incorporating Technetium 99m which comprises in a single sterile container a freeze-dried mixture of triethylene tetramine hexa (methylene phosphonic acid) or a water-soluble salt thereof and a water-soluble tin salt in a ratio by weight of from 10-100 parts of triethylene tetramine hexa (methylene phosphonic acid) and 1 part of tin as stannous chloride? dihydrate.
Claim 5
Dependent Claim
33 words
A kit in accordance with Claim 2 in which the weight ratio of the components is 40 parts of triethylene tetramine hexa (methylene phosphonic acid) and 1 part of tin as stannous chloride?dihydrate.
Claim 6
Dependent Claim
33 words
A kit in accordance with Claim 3 in which the triethylene tetramine hexa (methylene phosphonic acid) is present as the free acid and the tin is added in the form of stannous chloride?dihydrate.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.